Chronic (CRS) and acute (ARS) rhinosinusitis affect many people: Nearly 29.4 million U.S. adults have been diagnosed with sinusitis, and 11.7 million visits to physician offices resulted in a primary diagnosis of CRS, according to the U.S. Centers for Disease Control.
Explore this issue:May 2016
The sheer amount of information available about ARS and CRS pathology and treatment is staggering, however, and the condition continues to be the subject of ever-widening research.
To help clinicians and researchers better find evidence-based information, the International Forum of Allergy & Rhinology recently published the “International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR:RS).” The statement examines more than 140 topics relating to rhinosinusitis (RS), reviewing evidence-based studies and making recommendations based on that evidence (Int Forum Allergy Rhinol. 2016;6:S3-S21).